Screener
BioCryst Pharmaceuticals BCRX Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Research and development | 51,969 | 43,386 | 112,288 | 80,656 |
| Selling, general and administrative | 63,976 | 87,383 | 158,530 | 169,852 |
| Total operating expenses | 119,785 | 133,567 | 977,796 | 257,874 |
| Income (loss) from operations | 98,465 | 29,786 | (603,133) | 51,013 |
| Other income (expense): | ||||
| Interest income | 2,434 | 2,516 | 4,690 | 5,540 |
| Interest expense | (21,712) | (21,582) | (41,491) | (45,076) |
| Foreign currency gains (losses), net | 27 | (63) | (198) | (62) |
Item 1. Financial Statements (Unaudited):
FAQ
- What is BioCryst Pharmaceuticals's operating income?
- BioCryst Pharmaceuticals (BCRX) reported operating income of $98.47M in Q2 2026.
- How has BioCryst Pharmaceuticals's operating income changed year-over-year?
- BioCryst Pharmaceuticals's operating income increased by 230.6% year-over-year, from $29.79M to $98.47M.
- What is the long-term trend for BioCryst Pharmaceuticals's operating income?
- Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's operating income has grown at a 17.7% compound annual growth rate (CAGR), from -$177.72M to $340.99M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about BioCryst Pharmaceuticals's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude